XXXX due to @entity794 and enterococci in a general hospital.

@entity1 @entity5898 @entity794 @entity2886 @entity281 @entity1729 @entity580 @entity1793
Hospital acquired @entity281 caused by enterococci are increasing in incidence. This increase has been attributed, in part, to widespread use of @entity5898 antibiotics which lack activity against enterococci. To test this hypothesis, we compared @entity1 having @entity580 with those @entity1 having nosocomial @entity1793 for antecedant @entity5898 use. In a six month period, we found 14 instances of nosocomial enterococcal wound and @entity1729 ; 13 were superinfections (occurring during or up to one week after administration of antimicrobials). Seven had coexisting pathogens noted. In the same six month period, 30 instances of @entity794 nosocomial respiratory tract and wound @entity281 were found and only 13 were superinfections (p less than 0.002 compared with enterococcal superinfections). Nine had coexisting pathogens noted. The mean age, gender distribution and underlying illnesses in the @entity794 and enterococcal superinfection groups were comparable. Of the 14 instances of @entity580 , 11 were associated with administration of a @entity5898 compared with seven of 30 for @entity1793 (p less than 0.002). @entity580 are commonly associated with antimicrobial therapy and the use of @entity2886 may selectively predispose @entity1 to increased risk of enterococcal superinfections.
